MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Quaker BioVentures
*Portfolio Companies: Quaker BioVentures
NuPathe (NASDAQ: PATH)
Organization & Developments: NuPathe
Parents
NuPathe (NASDAQ: PATH)
Children
2012: Migraine pain patch developer NuPathe raises $28M in private stock sale (2012)
Lead product, NP101, uses SmartRelief, the company’s novel, transdermal patch technology to deliver sumatriptan to treat migrain
Pharmaceutical company developing therapies for improved treatment of such neurological and psychiatric disorders as migraine, P
The company’s Zelrix transdermal patch transmits sumatriptan with an electrical charge through the skin in a drug-delivery method known as iontophoresis.
Jumps
*Key People: NuPathe
Finance & Acquisitions: NuPathe